LASP1, CERS6, and Actin Form a Ternary Complex That Promotes Cancer Cell Migration

Area of Science:

• Oncology
• Cell Biology
• Biochemistry

Background:

• Ceramide synthase 6 (CERS6) is implicated in non-small cell lung cancer (NSCLC) metastasis and poor prognosis.
• The precise molecular mechanisms underlying CERS6-driven cell migration remain unclear.

Purpose of the Study:

• To identify novel binding partners of CERS6.
• To elucidate the role of CERS6 and its interacting proteins in NSCLC cell migration and metastasis.

Main Methods:

• Co-immunoprecipitation assays to identify CERS6 binding partners.
• Liquid chromatography and tandem mass spectrometry (LC-MS/MS) for protein identification.
• Immunofluorescence microscopy for co-localization studies.
• Cell migration and lamellipodia formation assays.
• Western blotting and gene silencing techniques.

Main Results:

• LASP1 was identified as a novel binding partner of CERS6, potentially interacting via its LIM domain.
• CERS6 and LASP1 co-localize on lamellipodia in NSCLC cell lines.
• Silencing of CERS6 or LASP1 significantly inhibited cell migration and lamellipodia formation.
• The CERS6-LASP1 complex interacts with actin, suggesting a role in cytoskeletal dynamics.
• Ectopic C16 ceramide addition partially rescued migration defects.

Conclusions:

• The interaction between CERS6 and LASP1 is a key driver of cancer cell migration in NSCLC.
• This interaction influences lamellipodia formation and actin dynamics, contributing to metastasis.
• Targeting the CERS6-LASP1 complex may offer a therapeutic strategy for NSCLC.